On Monday, September 21, 2020, the House of Representatives unanimously passed the Maternal Health Quality Improvement Act (H.R. 4995).
This legislation seeks to address the country’s maternal morbidity crisis through the implementation of rural obstetric networks, maternal telehealth programs, staff-focused implicit bias training, and integrated health care services for pregnant and postpartum women.
In a statement applauding its passage, the president of the American College of Obstetrics and Gynecologists (ACOG) urged the U.S. Senate to pass and sign the Maternal Health Quality Improvement Act into law by the end of 2020.
“The pandemic has underscored the importance of the Medicaid program, which already plays a critical role in maternity care—covering 43 percent of births nationwide. By also passing H.R. 4996, the House and Senate would support state efforts to extend Medicaid coverage beyond the standard 60 days to one year postpartum and close critical coverage gaps for women after pregnancy,” the statement read.
If signed into law, H.R. 4995 will provide $65 million annually for perinatal quality collaboratives, which unite health care providers to develop and implement programs to address underlying causes of maternal mortality and morbidity. It would also provide medical and nursing schools $5 million annually for courses on reducing and preventing discrimination with implicit bias training.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More